Profile
Matthew D.
Ronsheim is Chief Operating Officer at Xenon Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Ronsheim was Executive Director & Head-Chemistry Manufacturing at Enanta Pharmaceuticals, Inc. from 2016 to 2019 and Chief Pharmaceutical Sciences Officer at Entasis Therapeutics Holdings, Inc. Education includes undergraduate studies at Southern Connecticut State University and a doctorate from the University of New Hampshire.
Matthew Ronsheim active positions
| Companies | Position | Start |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Chief Operating Officer | 12/08/2024 |
Former positions of Matthew Ronsheim
| Companies | Position | End |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Director/Board Member | 01/08/2019 |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Corporate Officer/Principal | - |
Training of Matthew Ronsheim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Xenon Pharmaceuticals, Inc.
Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Southern Connecticut State University
Southern Connecticut State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New Hampshire
University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Entasis Therapeutics Holdings, Inc.
Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
- Stock Market
- Insiders
- Matthew Ronsheim
















